Cervical cancer is one of the most common cancers in women worldwide, however we are one step closer to eradicating it in the United States. Cervical cancer has been linked to the Human Papillomavirus (HPV), a very common infection that can be passed from person to person through sexual contact. Initially, screening for cervical cancer was performed using the Pap test.  Now, the presence of HPV can also be detected in addition to the Pap test. 

More than 30 types of HPV can infect the genital areas of a woman or a man. Some types may cause genital warts while others may cause abnormal cells, which if left untreated, can cause cancer of the cervix over a period of time. For those who may already be exposed to HPV, it is important to follow the doctor’s recommendations for evaluation, treatment and follow-up. Since cervical cancer takes many years to develop, early testing and treatment will prevent further problems. In June 2006, the FDA approved a vaccine, Gardasil, which is now available. The vaccine should be given to all girls aged 11 to 12, and to all females aged 13 to 26 who have not been previously vaccinated. This is the first step in preventing exposure to the four most common HPV types.